What is Biostate Ai?
Biostate AI is at the forefront of developing generative artificial intelligence solutions specifically designed to enhance human health. The company's core philosophy recognizes biological systems as dynamic entities, acknowledging the inherent individuality and daily fluctuations within each organism. By focusing on these intricate biological nuances, Biostate AI aims to create AI that can profoundly benefit global health outcomes, positioning itself as a key innovator in the health-tech and AI landscape.
How much funding has Biostate Ai raised?
Biostate Ai has raised a total of $16M across 2 funding rounds:
Other Financing Round
$4M
Series A
$12M
Other Financing Round (2024): $4M with participation from Catapult VC, Vision Plus, and Matter Venture Partners MVP
Series A (2025): $12M led by Gaingels, Catapult Ventures, Info Edge Ventures, Vision Plus Capital, Matter Venture Partners MVP, Mana Ventures, and Accel
Key Investors in Biostate Ai
Catapult VC
Catapult VC is a global venture capital platform dedicated to supporting entrepreneurs building transformational companies that address fundamental human needs. They focus on driving meaningful innovation across various industries.
Matter Venture Partners MVP
Matter Venture Partners MVP is a venture firm specializing in accelerating HardTech innovations, providing hands-on support to founders and leveraging deep operational experience to scale impactful technologies.
Gaingels
Gaingels is a leading investment syndicate supporting the LGBTQ community and allies in venture capital, investing in companies with LGBT founders and C-suite leaders, as well as inclusive teams.
What's next for Biostate Ai?
With the recent major strategic investment and substantial total funding, Biostate Ai is poised for accelerated development and market expansion. The company is likely to leverage this capital to scale its research and development efforts, enhance its AI platforms, and potentially forge new strategic partnerships within the healthcare and biotechnology industries. This infusion of backing suggests a strong investor confidence in Biostate Ai's vision and its capacity to deliver transformative AI-driven health solutions, signaling a period of significant growth and innovation.
See full Biostate Ai company page
